Ono Pharmaceutical has entered a collaboration with BioFocus, the service division of Galapagos NV, for the discovery of novel drugs in the field of CNS disorders. BioFocus will use its drug discovery platform to deliver leads and clinical candidates to Ono. Financial details were not disclosed.   “We are delighted to have this new agreement, which is the first drug discovery program with this, a most valued, client,” said Dr. Chris Newton, senior vice president of Galapagos Services...